You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-LMO1 (LMO1) Antibodies

Full name:
anti-LIM Domain Only 1 Antibodies (LMO1)
On are 21 LIM Domain Only 1 (LMO1) Antibodies from 4 different suppliers available. A total of 22 LMO1 products are currently listed.
list all antibodies Gene Name GeneID UniProt
LMO1 245979  
LMO1 13162 Q61327
LMO1 6531 Q01959

Show all species

Show all synonyms

Most Popular Reactivities for anti-LMO1 (LMO1) Antibodies

Select your species and application

anti-Rat (Rattus) LMO1 Antibodies:

anti-Mouse (Murine) LMO1 Antibodies:

anti-Human LMO1 Antibodies:

All available anti-LMO1 Antibodies

Go to our pre-filtered search.

More Antibodies against LMO1 Interaction Partners

Mouse (Murine) LIM Domain Only 1 (LMO1) interaction partners

  1. Data suggest that environment pollutants methylmercury and 1-methyl-4-phenylpyridinium decrease release of dopamine from dopaminergic neurons; this mechanism involves down-regulation of expression of Slc6a3 (show SLC6A3 Antibodies).

  2. This study show that Dopamine transporter is enriched in filopodia and induces filopodia formation.

  3. The sigma-1R deficiency through suppressing NR2B (show GRIN2B Antibodies) function and DAT (show SLC6A3 Antibodies) expression can reduce MPTP (show PTPN2 Antibodies)-induced death of dopaminergic neurons and parkinsonism.

  4. DAT (show SLC6A3 Antibodies) gene knockout in mice results dendritic spine loss in pyramidal neurons in the CA1 (show CA1 Antibodies) field of the hippocampus.

  5. Results show that moderate increases in DAT (show SLC6A3 Antibodies) function cause spontaneous dopaminergic cell loss, oxidative stress and fine motor impairment that is reversed by l-DOPA treatment

  6. Chronic and acute reductions of DAT (show SLC6A3 Antibodies) functioning in mice impaired decision-making.

  7. These results demonstrate that the presence of the N-terminal tag leads to impaired DAT (show SLC6A3 Antibodies) protein expression in vivo due in part to improper trafficking of the tagged transporter.

  8. studies demonstrate an in vivo functional impact of the DAT (show SLC6A3 Antibodies) Val559 variant, providing support for the ability of DAT (show SLC6A3 Antibodies) dysfunction to impact risk for mental illness.

  9. The data of this study imply that individual differences in DAT (show SLC6A3 Antibodies) expression (either genetically or pharmacologically induced) may affect susceptibility to addiction of different types of psychostimulants.

  10. findings support the idea that altered DAT (show SLC6A3 Antibodies) and VMAT2 (show Slc18a2 Antibodies) expression affect age-related changes in dopaminergic function.

Human LIM Domain Only 1 (LMO1) interaction partners

  1. total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers

  2. Data indicate genetic association between dopamine transporter SLC6A3 (DAT1) and hypertension, and the specific variable number tandem repeats (VNTR) alleles of SLC6A3 may be a risk factor for hypertension.

  3. The effects of parenting on self-control and offending are most pronounced for those who carry plasticity alleles for both MAOA (show MAOA Antibodies) and DAT1. Thus, MAOA (show MAOA Antibodies) and DAT1 may be implicated in offending because they increase the negative effects of parenting on self-control. Implications for theory are discussed.

  4. The presence of particular variants of variable number tandem repeat polymorphisms in 3' untranslated region of SLC6A3 (show SLC6A3 Antibodies) gene in men is associated with predisposition to certain forms of antisocial behavior.

  5. Increased nigral SLC6A3 activity may be a risk factor for SCZ.

  6. DRD4 (show DRD4 Antibodies) and SLC6A3 (show SLC6A3 Antibodies) gene polymorphisms may have a role in food intake and nutritional status in children in early stages of development

  7. Our findings suggest that rare high-risk copy number variations affecting the gene encoding the dopamine transporter contribute to the pathogenesis of schizophrenia and affective disorders.

  8. Compared with healthy controls, opioid-dependent individuals showed a significant reduction in striatal DAT (show SLC6A3 Antibodies) density, which also negatively correlated with non-perseverative errors in working memory.

  9. Study failed to observe a significant association of the SLC6A3 (show SLC6A3 Antibodies) 40-base pair variable number of tandem repeats polymorphism (rs28363170) with cognitive function in healthy adults

  10. the 3'-UTR (show UTS2R Antibodies) VNTR polymorphism is significantly associated with smoking cessation, and smokers with one or more 9-repeat alleles have a 17% higher probability of smoking cessation than smokers carrying no such allele. [meta-analysis]

LMO1 Antigen Profile

Antigen Summary

This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.

Alternative names and synonyms associated with LMO1

  • LIM domain only 1 (Lmo1) antibody
  • solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (Slc6a3) antibody
  • solute carrier family 6 (neurotransmitter transporter), member 3 (SLC6A3) antibody
  • solute carrier family 6 (neurotransmitter transporter), member 3 (Slc6a3) antibody
  • DAT antibody
  • DAT1 antibody
  • Lmo3 antibody
  • PKDYS antibody

Protein level used designations for LMO1

LIM domain only protein 3 , LMO-3 , LIM domain only 3 , neuronal-specific transcription factor DAT1 , dopamine-inducible LIM-domain transcription factor DAT1 , DA transporter , dopamine transporter 1 , sodium-dependent dopamine transporter , solute carrier family 6 member 3 , solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 , DAT , solute carrier family 6, member 3

245979 Rattus norvegicus
13162 Mus musculus
6531 Homo sapiens
24898 Rattus norvegicus
Selected quality suppliers for anti-LMO1 (LMO1) Antibodies
Did you look for something else?